Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Axogen Inc (NASDAQ: AXGN) closed at $15.61 down -0.64% from its previous closing price of $15.71. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 0.83 million shares were traded. AXGN stock price reached its highest trading level at $15.62 during the session, while it also had its lowest trading level at $15.24.
Ratios:
For a deeper understanding of Axogen Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 145.40. For the most recent quarter (mrq), Quick Ratio is recorded 2.67 and its Current Ratio is at 4.14. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 09 ’25 when Weiler Kathy Johnson sold 4,073 shares for $10.61 per share. The transaction valued at 43,215 led to the insider holds 6,580 shares of the business.
Levine Alan M sold 4,073 shares of AXGN for $43,215 on Jun 09 ’25. The Director now owns 36,743 shares after completing the transaction at $10.61 per share. On Jun 09 ’25, another insider, Wendell Amy McBride, who serves as the Director of the company, sold 4,073 shares for $10.61 each. As a result, the insider received 43,215 and left with 93,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 718256640 and an Enterprise Value of 758600256. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 6.36. Its current Enterprise Value per Revenue stands at 3.732 whereas that against EBITDA is 87.71.
Stock Price History:
The Beta on a monthly basis for AXGN is 1.03, which has changed by 0.17811322 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $21.00, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 17.94%, while the 200-Day Moving Average is calculated to be 4.68%.
Shares Statistics:
For the past three months, AXGN has traded an average of 1.27M shares per day and 1344530 over the past ten days. A total of 45.77M shares are outstanding, with a floating share count of 43.53M. Insiders hold about 5.40% of the company’s shares, while institutions hold 87.99% stake in the company. Shares short for AXGN as of 1755216000 were 3053163 with a Short Ratio of 2.41, compared to 1752537600 on 3087285. Therefore, it implies a Short% of Shares Outstanding of 3053163 and a Short% of Float of 6.83.
Earnings Estimates
The current rating of Axogen Inc (AXGN) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.09, with high estimates of $0.13 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.37 and $0.21 for the fiscal current year, implying an average EPS of $0.26. EPS for the following year is $0.47, with 5.0 analysts recommending between $0.6 and $0.41.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $56.89M this quarter.It ranges from a high estimate of $57.2M to a low estimate of $56M. As of the current estimate, Axogen Inc’s year-ago sales were $48.64MFor the next quarter, 7 analysts are estimating revenue of $57.57M. There is a high estimate of $57.9M for the next quarter, whereas the lowest estimate is $57M.
A total of 7 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $220.3M, while the lowest revenue estimate was $219M, resulting in an average revenue estimate of $219.65M. In the same quarter a year ago, actual revenue was $187.34MBased on 7 analysts’ estimates, the company’s revenue will be $254.05M in the next fiscal year. The high estimate is $260M and the low estimate is $249.7M.
